NeurAxis, Inc. (NYSEAM: NRXS)
Health Care · Health Care Equipment & Supplies · US
$6.57
-5.19% today · +125.7% 1Y
NeurAxis, Inc. (NYSEAM: NRXS) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $87.03M and employs 24 people.
Over the last twelve months the share price has gained 125.7%, trading between 2.21 and 9.33.
Tweenvest scores NeurAxis, Inc. across four factors: quality 42/100, value 64/100, growth 60/100. Its strongest factor is value.
NRXS price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $87.03M
- Revenue (TTM)
- $5.32M
- P/E
- —
- EPS
- -0.78
- Dividend yield
- —
- Beta (5Y)
- 1.36
- 52-week high
- $9.33
- 52-week low
- $2.21
- Avg volume (3M)
- —
- Shares outstanding
- 12.56M
- Employees
- 24
- Next earnings
- —
About NeurAxis, Inc.
NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. The firm, headquartered in Carmel, Indiana, was established in 2011 and operated as Innovative Health Solutions, Inc. until its rebranding to NeurAxis, Inc. in March 2022.
- ISIN
- US64134X2018
- Founded
- 2011
- Listed since
- Aug 9, 2023
- Exchange
- NYSE American LLC
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Streamex Corp.NasdaqCM: STEX | $91.02M | $0.47 | -3.26% |
| Applied BioCode CorporationTWSE: 6598 | $88.75M | NT$27.60 | +1.28% |
| Techno Medica Co., Ltd.TSE: 6678 | $87.87M | ¥1,997.00 | -0.15% |
| electroCore, Inc.NasdaqCM: ECOR | $87.09M | $9.34 | -3.31% |
| Colan Totte.Co.,Ltd.TSE: 7792 | $85.26M | ¥1,484.00 | -0.20% |
| Solborn, Inc.KOSDAQ: A035610 | $84.34M | ₩4,965.00 | +1.43% |
| OPTUS Pharmaceutical Co., Ltd.KOSDAQ: A131030 | $83.48M | ₩6,360.00 | +1.92% |
| Nexstim PlcHLSE: NXTMH | $83.18M | €9.18 | -0.22% |
Figures last refreshed Oct 11, 2026.